000			01381 a2200373 4500
005			20250511230114.0
264		0	_c19901012
008			199010s 0 0 eng d
022			_a0894-9255
040			_aNLM _beng _cNLM
100	1		_aArchibald, D W
245	0	0	_aSalivary antibodies to human immunodeficiency virus type 1 in a phase I AIDS vaccine trial. _h[electronic resource]
260			_bJournal of acquired immune deficiency syndromes _c1990
300			_a954-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aBlotting, Western
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Evaluation
650	0	4	_aGene Products, env _ximmunology
650	0	4	_aHIV Antibodies _xbiosynthesis
650	0	4	_aHIV Envelope Protein gp160
650	0	4	_aHIV-1 _ximmunology
650	0	4	_aHumans
650	0	4	_aImmunoglobulin A, Secretory _xbiosynthesis
650	0	4	_aProtein Precursors _ximmunology
650	0	4	_aRecombinant Proteins _ximmunology
650	0	4	_aSaliva _ximmunology
650	0	4	_aVaccines, Synthetic _ximmunology
650	0	4	_aViral Vaccines _ximmunology
700	1		_aHebert, C A
700	1		_aSun, D
700	1		_aTacket, C O
773	0		_tJournal of acquired immune deficiency syndromes _gvol. 3 _gno. 10 _gp. 954-8
999			_c2210819 _d2210819